Formally known as the International AIDS Conference (IAC), the first AIDS event took place in Atlanta in 1985 and was organised by the Centers for Disease Control and Prevention (CDC), the World Health Organisation (WHO), and Emory University. More than 2000 scientists, activists and public health officials came together to share information on HIV and AIDS as an emerging epidemic. Now organised by the International AIDS Society (IAS), the AIDS 2024 conference is expected to host over 15,000 scientists, healthcare professionals and people living with and affected by HIV to share the latest data and lessons learnt from the HIV response over the past 40 years.


Join us at AIDS 2024, the 25th International AIDS Conference (IAS), happening in Munich, Germany from 22-26 July. This conference is a crucial platform for us to showcase our latest advances in HIV treatment and prevention innovation, as well as our long-standing partnership with the HIV Community. We are also incredibly excited to celebrate the 20th anniversary of the Global Village as the sole sponsors. The dynamic and vibrant atmosphere in the village is always a highlight of the conference and we look forward to seeing you all there.

Our employees and community partners talk about how science can help combat HIV Stigma and contribute to the end of the HIV epidemic.

Showcasing our innovative portfolio and pipeline at AIDS 2024

Our ultimate goal is simple; to end the HIV epidemic. Until then, we will continue to explore new ways of treating and preventing HIV in order to achieve our mission of leaving no person living with HIV behind.

Abstracts from our innovative pipeline and portfolio will emphasise our commitment to meeting the evolving wants and needs of the HIV community, including new data and findings for our existing HIV therapies, as well as the next generation, including 2-drug and long-acting regimens.

We know that people living with HIV and those who can benefit from PrEP want more options and that’s why we’re exploring new ways of treating and preventing HIV through new approaches in how we target the virus as well as the process of how medicines are administered.

You can find out more about the conference programme here.

Partnering with the community

We’re proud of our enduring commitment to the HIV community, whether it be through our 30+ year Positive Action Programme or through our digital campaigns, collaborating as partners, advocates, and champions to address the issues that matter most. At AIDS 2024, we’ll be using our platform to amplify the voices of the HIV community, ensuring that their voices are heard, shining a spotlight on the communities that are disproportionately impacted by HIV. We’re excited to be facilitating several events throughout the week of the conference:

  • HIV Science as Art: Organised by Münchner Aidshilfe, the first regional AIDS aid organisation in Germany. We’re proud to be the exclusive supporters of HIV Science as Art, a groundbreaking exhibition merging the talents of 12 artists living with HIV with 12 scientists across the globe. Together, they produce 12 original artworks, spotlighting both the advancements in HIV science and the human dimension of living with the virus. The artwork will be displayed in The Brainlab Tower from 22 July. The artwork will be auctioned, and the money raised will go to fund projects supporting the HIV community in Eastern Europe.
  • Community event: AIDS 2024 delegates and our partners who are in Munich are welcome to join us on the evening of the 23 July for a community event focused on how we will end the epidemic. Bringing together people from across the HIV ecosystem, including local community groups, scientists, activists and policymakers. The event will provide an opportunity for networking and lively discussion on what should be the priority areas of focus and collaboration. This event will follow on from a symposium hosted by our Patient Engagement team earlier in the day focused on person-centred engagement across medicine development, healthcare, and advocacy.
  • Positive Action booth talks: Over the course of AIDS 2024, our Positive Action booth in the Global Village will be hosting a series of informal sessions, open to all attendees of the congress, on a range of topics including the role of digital storytelling and building an online community to educate and tackle stigma related to HIV, the importance of grassroots community-led advocacy and a discussion around collaborative approaches to HIV care in Germany. Click here for more details

Save the date and mark your calendars for AIDS 2024 in Munich, where innovation, collaboration, and progress converge for the benefit of all those living with and impacted by HIV.


Thanks to advances in science and innovation, people living with HIV have options for effective treatment that mean they can expect to live long and healthy lives. Find out why understanding the needs and wants of people living with HIV is essential.

Discover how achieving and maintaining an undetectable viral load prevents transmission of HIV and explore how U=U dispels stigma and promotes sex positivity.

For people living with HIV. Resources and information about living well with HIV.

For news and media. Latest news and press releases via our media centre.

For healthcare professionals, Information about ViiV medicines and data.

NP-GBL-HVX-COCO-230010 | June 2024

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.